Jennison Associates’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $45M | Buy |
|
|||||
|
2024
Q2 | $37.1M | Buy |
|
|||||
|
2024
Q1 | $28.9M | Buy |
|
|||||
|
2023
Q4 | $796K | Sell |
|
|||||
|
2023
Q3 | $740K | Sell |
|
|||||
|
2023
Q2 | $45.1M | Sell |
|
|||||
|
2023
Q1 | $56.9M | Buy |
|
|||||
|
2022
Q4 | $69.3M | Buy |
|
|||||
|
2022
Q3 | $35.8M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $39.2M | Sell |
|
|||||
|
2014
Q2 | $51.9M | Sell |
|
|||||
|
2014
Q1 | $61.6M | Sell |
|
|||||
|
2013
Q4 | $96.4M | Sell |
|
|||||
|
2013
Q3 | $151M | Sell |
|
|||||
|
2013
Q2 | $72.9M | Buy |
|